(Press-News.org) (Boston) - Boston University School of Medicine (BUSM) researchers recently uncovered a brain signaling pathway responsible for regulating the renal excretion of sodium. The findings appear in the Journal of the Federation of American Societies for Experimental Biology.
Hypertension, or chronic high blood pressure, affects one-third of adults, significantly increasing cardiovascular risk and mortality. Approximately 50 percent of hypertensive patients are salt-sensitive and exhibit an increase in blood pressure following salt-intake.
According to the researchers, little is known about the mechanisms acting in the brain to control the removal of dietary salt from the body through the kidneys. "Our data shows that changes in dietary sodium intake evoked natural site-specific changes in brain hypothalamic paraventricular nucleus (PVN) Gαi2 protein levels," said Senior Author Richard Wainford, PhD, assistant professor of pharmacology and experimental therapeutics.
Wainford and his team explored the role of Gαi2 signal transduction proteins in the brain pathways activated to regulate salt and water excretion and subsequently blood pressure. They identified a previously unknown role of PVN Gαi2-subunit proteins as a central mechanism mediating the suppression of renal sympathetic nerve traffic to the kidneys and the renal excretion of sodium.
These data provide a target for new therapies that may improve cardiovascular and renal excretory function. This may help treat multiple disease states, such as salt-sensitive hypertension and congestive heart failure caused by elevated sodium intake.
###This research was funded by the American Heart Association (AHA) and the National Heart Lung and Blood Institute (NHLBI).
BUSM researcher finds link between brain signaling and renal function
2012-06-05
ELSE PRESS RELEASES FROM THIS DATE:
New immune therapy shows promise in kidney cancer
2012-06-05
BOSTON – An antibody that helps a person's own immune system battle cancer cells shows increasing promise in reducing tumors in patients with advanced kidney cancer, according to researchers at Beth Israel Deaconess Medical Center.
The results of an expanded Phase 1 trial presented at the American Society of Clinical Oncology's annual conference in Chicago, showed that some patients treated with a fully human monoclonal antibody developed by Bristol Myers Squibb had a positive response to the effort by the agent, BMS-936558, to prolong the immune system's efforts to fight ...
Underground search for neutrino properties unveils first results
2012-06-05
Menlo Park, Calif. — Scientists studying neutrinos have found with the highest degree of sensitivity yet that these mysterious particles behave like other elementary particles at the quantum level. The results shed light on the mass and other properties of the neutrino and prove the effectiveness of a new instrument that will yield even greater discoveries in this area.
The Enriched Xenon Observatory 200 (EXO-200), an international collaboration led by Stanford University and the U.S. Department of Energy's (DOE) SLAC National Accelerator Laboratory, has begun one of ...
Vaccinations of US children declined after publication of now-refuted autism risk
2012-06-05
New University of Cincinnati research has found that fewer parents in the United States vaccinated their children in the wake of concerns about a purported link (now widely discredited) between the MMR (measles, mumps, rubella) vaccine and autism.
Lenisa Chang, assistant professor of economics in UC's Carl H. Lindner College of Business, found that the MMR-autism controversy, which played out prominently in the popular media following publication in a 1998 medical journal, led to a decline of about two percentage points in terms of parents obtaining the MMR vaccine for ...
Physicists close in on a rare particle-decay process
2012-06-05
PASADENA, Calif.—In the biggest result of its kind in more than ten years, physicists have made the most sensitive measurements yet in a decades-long hunt for a hypothetical and rare process involving the radioactive decay of atomic nuclei.
If discovered, the researchers say, this process could have profound implications for how scientists understand the fundamental laws of physics and help solve some of the universe's biggest mysteries—including why there is more matter than antimatter and, therefore, why regular matter like planets, stars, and humans exists at all. ...
Emergency department algorithm may predict risk of death for heart failure patients
2012-06-05
Physicians can reduce the number of heart failure deaths and unnecessary hospital admissions by using a new computer-based algorithm developed at the Institute for Clinical Evaluative Sciences (ICES) that calculates each patient's individual risk of death. Published in the Annals of Internal Medicine, the algorithm improves upon clinical decision-making and determines whether or not a patient with heart failure should be admitted to hospital. To bring this tool into the emergency departments, Peter Munk Cardiac Centre cardiologists are developing smartphone and web-based ...
June 2012 story tips from Oak Ridge National Laboratory
2012-06-05
MATERIALS – Transparent performance . . .
Windshields, windows, solar panels, eyeglasses, heart stents and hundreds of other products representing a multi-billion-dollar market are potential targets for Oak Ridge National Laboratory's thin-film superhydrophobic technology. Conventional commercially available products tend to lack transparency, suitable bonding capability or both, making them largely impractical, said Tolga Aytug, one of the developers. The ORNL product, based on glass, can be produced with manufacturing processes that are cost effective and easily scaled ...
Depression treatment can prevent adolescent drug abuse
2012-06-05
DURHAM, N.C. -- Treating adolescents for major depression can also reduce their chances of abusing drugs later on, a secondary benefit found in a five-year study of nearly 200 youths at 11 sites across the United States.
Only 10 percent of 192 adolescents whose depression receded after 12 weeks of treatment later abused drugs, compared to 25 percent of those for whom treatment did not work, according to research led by John Curry, a professor of psychology and neuroscience at Duke University.
"It turned out that whatever they responded to -- cognitive behavioral therapy, ...
Life expectancy prolonged for esophageal cancer patients
2012-06-05
Reston, Va. (June 4, 2012) – For those with esophageal cancer, initial staging of the disease is of particular importance as it determines whether to opt for a curative treatment or palliative treatment. Research presented in the June issue of The Journal of Nuclear Medicine shows that physicians using positron emission tomography (PET)/computed tomography (CT) can discern incremental staging information about the cancer, which can significantly impact management plans.
In 2012, an estimated 17,500 people will be diagnosed with esophageal cancer and 15,000 will die from ...
New research yields insights into Parkinson's disease
2012-06-05
Researchers at the University of Toronto Scarborough (UTSC) used an innovative technique to examine chemical interactions that are implicated in Parkinson's Disease.
The work details how a protein called alpha-synuclein interacting with the brain chemical dopamine can lead to protein misfolding and neuronal death.
Parkinson's Disease is a neurodegenerative disease which results in loss of motor control and cognitive function. Although the cause isn't known precisely, the disease involves the death of brain cells that produce dopamine, a chemical important in neuronal ...
Mature liver cells may be better than stem cells for liver cell transplantation therapy
2012-06-05
Tampa, Fla. (June 4, 2012) – After carrying out a study comparing the repopulation efficiency of immature hepatic stem/progenitor cells and mature hepatocytes transplanted into liver-injured rats, a research team from Sapporo, Japan concluded that mature hepatocytes offered better repopulation efficiency than stem/progenitor cells.
Until day 14 post-transplantation, the growth of the stem/progenitor cells was faster than the mature hepatocytes, but after two weeks most of the stem/progenitor cells had died. However, the mature hepatocytes continued to survive and proliferate ...